BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 16505355)

  • 1. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants.
    Sieving PA; Caruso RC; Tao W; Coleman HR; Thompson DJ; Fullmer KR; Bush RA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3896-901. PubMed ID: 16505355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa.
    Tao W; Wen R; Goddard MB; Sherman SD; O'Rourke PJ; Stabila PF; Bell WJ; Dean BJ; Kauper KA; Budz VA; Tsiaras WG; Acland GM; Pearce-Kelling S; Laties AM; Aguirre GD
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3292-8. PubMed ID: 12356837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases.
    Kauper K; McGovern C; Sherman S; Heatherton P; Rapoza R; Stabila P; Dean B; Lee A; Borges S; Bouchard B; Tao W
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7484-91. PubMed ID: 23049090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal injection of ciliary neurotrophic factor (CNTF) causes peripheral remodeling and does not prevent photoreceptor loss in canine RPGR mutant retina.
    Beltran WA; Wen R; Acland GM; Aguirre GD
    Exp Eye Res; 2007 Apr; 84(4):753-71. PubMed ID: 17320077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination of CNTF and BDNF rescues rd photoreceptors but changes rod differentiation in the presence of RPE in retinal explants.
    Caffé AR; Söderpalm AK; Holmqvist I; van Veen T
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):275-82. PubMed ID: 11133879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNTF induces regeneration of cone outer segments in a rat model of retinal degeneration.
    Li Y; Tao W; Luo L; Huang D; Kauper K; Stabila P; Lavail MM; Laties AM; Wen R
    PLoS One; 2010 Mar; 5(3):e9495. PubMed ID: 20209167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.
    Chew EY; Clemons TE; Jaffe GJ; Johnson CA; Farsiu S; Lad EM; Guymer R; Rosenfeld P; Hubschman JP; Constable I; Wiley H; Singerman LJ; Gillies M; Comer G; Blodi B; Eliott D; Yan J; Bird A; Friedlander M;
    Ophthalmology; 2019 Apr; 126(4):540-549. PubMed ID: 30292541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNTF induces dose-dependent alterations in retinal morphology in normal and rcd-1 canine retina.
    Zeiss CJ; Allore HG; Towle V; Tao W
    Exp Eye Res; 2006 Mar; 82(3):395-404. PubMed ID: 16143329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulated cell-based intraocular delivery of ciliary neurotrophic factor in normal rabbit: dose-dependent effects on ERG and retinal histology.
    Bush RA; Lei B; Tao W; Raz D; Chan CC; Cox TA; Santos-Muffley M; Sieving PA
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2420-30. PubMed ID: 15223826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dose-dependent macular thickness changes assessed by fd-oct in patients with retinitis pigmentosa treated with ciliary neurotrophic factor.
    Pilli S; Zawadzki RJ; Telander DG
    Retina; 2014 Jul; 34(7):1384-90. PubMed ID: 24368307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration.
    Schlichtenbrede FC; MacNeil A; Bainbridge JW; Tschernutter M; Thrasher AJ; Smith AJ; Ali RR
    Gene Ther; 2003 Mar; 10(6):523-7. PubMed ID: 12621456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment.
    Talcott KE; Ratnam K; Sundquist SM; Lucero AS; Lujan BJ; Tao W; Porco TC; Roorda A; Duncan JL
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2219-26. PubMed ID: 21087953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical instillation of ciliary neurotrophic factor inhibits retinal degeneration in streptozotocin-induced diabetic rats.
    Aizu Y; Katayama H; Takahama S; Hu J; Nakagawa H; Oyanagi K
    Neuroreport; 2003 Nov; 14(16):2067-71. PubMed ID: 14600499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.
    Liang FQ; Aleman TS; Dejneka NS; Dudus L; Fisher KJ; Maguire AM; Jacobson SG; Bennett J
    Mol Ther; 2001 Nov; 4(5):461-72. PubMed ID: 11708883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation.
    Bok D; Yasumura D; Matthes MT; Ruiz A; Duncan JL; Chappelow AV; Zolutukhin S; Hauswirth W; LaVail MM
    Exp Eye Res; 2002 Jun; 74(6):719-35. PubMed ID: 12126945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciliary neurotrophic factor (CNTF) delivery to retina: an overview of current research advancements.
    Ghasemi M; Alizadeh E; Saei Arezoumand K; Fallahi Motlagh B; Zarghami N
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1694-1707. PubMed ID: 29065723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular gene transfer of ciliary neurotrophic factor rescues photoreceptor degeneration in RCS rats.
    Huang SP; Lin PK; Liu JH; Khor CN; Lee YJ
    J Biomed Sci; 2004; 11(1):37-48. PubMed ID: 14730208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa.
    Birch DG; Weleber RG; Duncan JL; Jaffe GJ; Tao W;
    Am J Ophthalmol; 2013 Aug; 156(2):283-292.e1. PubMed ID: 23668681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNGB3-achromatopsia clinical trial with CNTF: diminished rod pathway responses with no evidence of improvement in cone function.
    Zein WM; Jeffrey BG; Wiley HE; Turriff AE; Tumminia SJ; Tao W; Bush RA; Marangoni D; Wen R; Wei LL; Sieving PA
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6301-8. PubMed ID: 25205868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNTF and retina.
    Wen R; Tao W; Li Y; Sieving PA
    Prog Retin Eye Res; 2012 Mar; 31(2):136-51. PubMed ID: 22182585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.